The particulars: tirzepatide · bacteriostatic water.
I would like the mechanism, because I want to be able to reason about the cases nobody has written about.
I have tried to reason it out from first principles and got to two contradictory conclusions.
What is actually going on here, physically?
Add the diluent down the vial wall rather than directly onto the cake. Peptides are surface-active and shear at an air–liquid interface, so a jet of water into a lyophilised puck generates foam, and foam is aggregated protein at the interface, not just air.
On re-freezing something that thawed in transit: if it arrived as a lyophilised solid that warmed but never got wet, re-freezing costs you nothing except the thermal cycle.
A 0.22 µm syringe filter will remove particulates and organisms, and it will also adsorb a fraction of your peptide.
Published data on syringe dead space in the context of injection-equipment programmes quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more.
The caveat is that this is not a recommendation to administer anything. Research-use-only material is not approved for human use.
None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsThe part that matters: this is not exotic. It is just the difference between doing it deliberately and doing it approximately.
Write the arithmetic on the vial label. It costs nothing and removes the step where you reconstruct it from memory at an inconvenient moment.
Check the barrel marking, not your memory of it.
Coring of elastomeric closures is a well-characterised failure mode in the parenteral packaging literature.
I would flag the obvious failure mode: people get the concentration right, get the volume right, and then read the syringe against the wrong scale.
Do the arithmetic twice, ideally with someone else doing it independently.
Worth being precise here: reconstitution is the step where most hands-on errors enter the system, which is why spending time on technique here pays off more than anywhere else.
Photograph the vial against a matte black card with a single point light source off to one side, not with a flash from the front.
In practice, tilting the vial to pool solution in the corner before the final draw, and giving it a minute to drain down the walls, genuinely recovers ten to twenty microlitres.
The general principle — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science.
Worth saying: if your arithmetic and someone else's disagree by a factor of ten, one of you has made a unit error.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.
edited 14 May 2025 by kirsi_lahtinen — added a caveat about sampling
More usefully, sodium chloride 0.9 per cent as a diluent is not a neutral substitution. Ionic strength affects peptide solubility and aggregation propensity.
Room temperature before drawing is worth the ten minutes. Cold solution is more viscous, draws slower, and is more likely to pull a bubble past the plunger seal.
One limitation: technique reduces risk, it does not remove it.
None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.
Put another way, the distinction that resolves most of these questions is that bacteriostatic water suppresses microbial growth and does not sterilise anything. It buys you a multiple-withdrawal presentation; it does not make an unsterile preparation sterile, and it does not substitute for technique.
Do not use the same needle to pierce the stopper and to administer.
The 28-day beyond-use convention for a multiple-withdrawal preserved preparation derives from USP compounding chapters, which set it on microbiological risk rather than chemical stability.
Do the arithmetic twice, ideally with someone else doing it independently.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.